Making an IMPACT: Donation keeps innovative trials going
Monday, August 4, 2014 - 11:30
in Health & Medicine
The method of treating cancer patients who have genomic abnormalities with drugs designed to target those abnormalities has resulted in higher response rates than previously seen. Often these discoveries are made as part of a clinical trial. Innovation of trial design and the need to streamline established processes for developing and executing these studies is more important than ever.